Cardiac Signaling Center of University of South Carolina, Medical University of South Carolina and Clemson University, Charleston, SC 29245, USA.
J Physiol. 2012 Sep 1;590(17):4223-37. doi: 10.1113/jphysiol.2012.236570. Epub 2012 Jul 2.
Acute and chronic hypoxias are common cardiac diseases that lead often to arrhythmia and impaired contractility. At the cellular level it is unclear whether the suppression of cardiac Ca(2+) channels (Ca(V)1.2) results directly from oxygen deprivation on the channel protein or is mediated by intermediary proteins affecting the channel. To address this question we measured the early effects of hypoxia (5-60 s, P(O(2)) < 5 mmHg) on Ca(2+) current (I(Ca)) and tested the involvement of protein kinase A (PKA) phosphorylation, Ca(2+)/calmodulin-mediated signalling and the haem oxygenase (HO) pathway in the hypoxic regulation of Ca(V)1.2 in rat and cat ventricular myocytes and HEK-293 cells. Hypoxic suppression of ICa) and Ca(2+) transients was significant within 5 s and intensified in the following 50 s, and was reversible. Phosphorylation by cAMP or the phosphatase inhibitor okadaic acid desensitized I(Ca) to hypoxia, while PKA inhibition by H-89 restored the sensitivity of I(Ca) to hypoxia. This phosphorylation effect was specific to Ca(2+), but not Ba(2+) or Na(+), permeating through the channel. CaMKII inhibitory peptide and Bay K8644 reversed the phosphorylation-induced desensitization to hypoxia. Mutation of CAM/CaMKII-binding motifs of the α(1c) subunit of Ca(V)1.2 fully desensitized the Ca(2+) channel to hypoxia. Rapid application of HO inhibitors (zinc protoporphyrin (ZnPP) and tin protoporphyrin (SnPP)) suppressed the channel in a manner similar to acute hypoxia such that: (1) I(Ca) and I(Ba) were suppressed within 5 s of ZnPP application; (2) PKA activation and CaMKII inhibitors desensitized I(Ca), but not I(Ba), to ZnPP; and (3) hypoxia failed to further suppress I(Ca) and I(Ba) in ZnPP-treated myocytes. We propose that the binding of HO to the CaM/CaMKII-specific motifs on Ca(2+) channel may mediate the rapid response of the channel to hypoxia.
急性和慢性缺氧是常见的心脏疾病,常常导致心律失常和收缩功能障碍。在细胞水平上,尚不清楚心脏 Ca(2+) 通道(Ca(V)1.2)的抑制是直接由通道蛋白缺氧引起的,还是由影响通道的中间蛋白介导的。为了解决这个问题,我们测量了缺氧(5-60 秒,P(O(2)) < 5 mmHg)对 Ca(2+) 电流(I(Ca))的早期影响,并测试了蛋白激酶 A (PKA) 磷酸化、Ca(2+) /钙调蛋白介导的信号转导和血红素加氧酶 (HO) 途径在调节 Ca(V)1.2 在大鼠和猫心室肌细胞和 HEK-293 细胞中的作用。缺氧抑制 ICa) 和 Ca(2+) 瞬变在 5 秒内显著,并在接下来的 50 秒内加剧,且是可逆的。cAMP 或磷酸酶抑制剂 okadaic 酸的磷酸化使 I(Ca)对缺氧脱敏,而 H-89 抑制 PKA 则恢复了 I(Ca)对缺氧的敏感性。这种磷酸化作用是特异性的,与 Ca(2+),而不是 Ba(2+)或 Na(+),通过通道。钙调蛋白依赖性激酶 II 抑制肽和 Bay K8644 逆转了磷酸化诱导的对缺氧的脱敏作用。Ca(V)1.2 的 α(1c)亚基的 CAM/CaMKII 结合基序的突变使钙通道对缺氧完全脱敏。快速应用 HO 抑制剂(锌原卟啉 (ZnPP) 和锡原卟啉 (SnPP)) 以类似于急性缺氧的方式抑制通道,使得:(1)ZnPP 应用后 5 秒内 I(Ca)和 I(Ba)被抑制;(2)PKA 激活和钙调蛋白依赖性激酶 II 抑制剂使 I(Ca)脱敏,但不使 I(Ba)脱敏,对 ZnPP;(3)ZnPP 处理的肌细胞中,缺氧不能进一步抑制 I(Ca)和 I(Ba)。我们提出,HO 与 Ca(2+) 通道上的 CaM/CaMKII 特异性基序的结合可能介导了通道对缺氧的快速反应。